Alvotech

Company Profile

Alvotech had its IPO on 2022-06-16 under the ticker symbol ALVO.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Alvotech has a staff strength of 784 employees.

Stock update

Shares of Alvotech opened at $9.61 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $9.32 - $9.67, and closed at $9.36.

This is a -1.58% slip from the previous day's closing price.

A total volume of 12,078 shares were traded at the close of the day’s session.

In the last one week, shares of Alvotech have slipped by -5.84%.

Alvotech's Key Ratios

Alvotech has a market cap of $3.67 billion, indicating a price to book ratio of 0 and a price to sales ratio of 20.6922.

In the last 12-months Alvotech’s revenue was $85.02 million with a gross profit of $20.92 million and an EBITDA of $-333569984. The EBITDA ratio measures Alvotech's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Alvotech’s operating margin was -404.26% while its return on assets stood at -30.12% with a return of equity of 0%.

In Q4, Alvotech’s quarterly earnings growth was a positive 0% while revenue growth was a negative 30.2%.

Alvotech’s PE and PEG Ratio

Forward PE

0

Trailing PE

55.96

PEG

Its diluted EPS in the last 12-months stands at $0.25 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Alvotech’s profitability.

Alvotech stock is trading at a EV to sales ratio of 28.6123 and a EV to EBITDA ratio of 29.6456. Its price to sales ratio in the trailing 12-months stood at 20.6922.

Alvotech stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$828.44 million

Total Liabilities

$167.29 million

Operating Cash Flow

$0

Capital Expenditure

$10.47 million

Dividend Payout Ratio

0%

Alvotech ended 2024 with $828.44 million in total assets and $0 in total liabilities. Its intangible assets were valued at $828.44 million while shareholder equity stood at $-564416000.00.

Alvotech ended 2024 with $0 in deferred long-term liabilities, $167.29 million in other current liabilities, in common stock, $-1654114000.00 in retained earnings and $11.64 million in goodwill. Its cash balance stood at $66.43 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $744.65 million.

Alvotech’s total current assets stands at $230.74 million while long-term investments were $48.57 million and short-term investments were $0. Its net receivables were $32.97 million compared to accounts payable of $49.19 million and inventory worth $71.47 million.

In 2024, Alvotech's operating cash flow was $0 while its capital expenditure stood at $10.47 million.

Comparatively, Alvotech paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$9.36

52-Week High

$14.6

52-Week Low

$5.2

Analyst Target Price

$12.8

Alvotech stock is currently trading at $9.36 per share. It touched a 52-week high of $14.6 and a 52-week low of $14.6. Analysts tracking the stock have a 12-month average target price of $12.8.

Its 50-day moving average was $9.33 and 200-day moving average was $10.2 The short ratio stood at 4.2 indicating a short percent outstanding of 0%.

Around 7364.3% of the company’s stock are held by insiders while 758.6% are held by institutions.